Close Menu

NEW YORK – Exact Sciences has received a letter from the US Food and Drug Administration granting it Emergency Use Authorization for an in vitro diagnostic assay for the detection of SARS-CoV-2.

The SARS-CoV-2 RT-PCR assay test, which will be performed at Exact's CLIA-certified lab, is a real-time PCR assay intended for the qualitative detection of the virus' nucleic acids in nasal, nasopharyngeal, and oropharyngeal patient swabs.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.